SCHEMBL5316092

SCHEMBL5316092

Cc1ccccc1OCCCOc1ccc2c3ccccc3n(CC(=O)O)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 7/20 0.52
PSEN2 P49810 7/20 0.52
APH1B Q8WW43 7/20 0.52
NCSTN Q92542 7/20 0.52
APH1A Q96BI3 7/20 0.52
PSENEN Q9NZ42 7/20 0.52
KDM4E B2RXH2 3/20 0.51
PDPK1 O15530 1/20 0.49
MCL1 Q07820 1/20 0.48
PPARG P37231 3/20 0.48
PPARD Q03181 2/20 0.48
ALDH1A1 P00352 1/20 0.47
PPARA Q07869 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5317818 0.97 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5317719 0.87 KDM4E (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5317917 0.87 KDM4E (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5316844 0.87 LMNA (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152552 0.87 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156083 0.87 KDM4E (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156262 0.87 KDM4E (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156287 0.87 MCL1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5156113 0.86 PSEN1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151346 0.86 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 PSEN1 2971/4885PSEN2 1240/4885APH1B 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.